Rising Demand for Radiofrequency Ablation Devices Market Driven by Chronic Pain and Cardiovascular Diseases
Discover the rising demand for Radiofrequency Ablation (RFA) devices driven by chronic pain and cardiovascular diseases.
VANCOUVER, BC, CANADA, June 28, 2024 /EINPresswire.com/ -- The global Radiofrequency Ablation (RFA) devices market size was USD 4.30 Billion in 2022 and is expected to register a rapid revenue CAGR of 12.0% during the forecast period. The global Radiofrequency Ablation (RFA) devices market is experiencing significant growth, driven by the increasing prevalence of chronic pain disorders and cardiovascular diseases (CVDs), as well as rising healthcare expenditures. Radiofrequency ablation, a minimally invasive procedure, is widely used for treating cardiac conditions such as atrial fibrillation, cancer, and pain management.
Cardiovascular diseases are a leading cause of death globally, accounting for 17.9 million deaths annually. Heart attacks and strokes contribute to over 80% of these deaths, many of which occur prematurely in individuals under 70. Radiofrequency ablation is highly favored for its effectiveness, ease of use, and safety in treating various conditions, including cardiac arrhythmias and cancer.
To Receive A PDF Sample Of The Report, Visit @https://www.emergenresearch.com/request-sample/2631
Market Drivers
The market is propelled by the high efficacy of RF ablation in creating controlled heart tissue damage. However, challenges like collateral damage and the heat sink effect persist. Alternatives such as cryoablation and irreversible electroporation (IRE) show promise in minimizing these issues.
Technological advancements in RF ablation devices are also contributing to market growth. Innovations like multimodality imaging and sophisticated computational models enhance the precision and effectiveness of RF ablation procedures, ultimately improving patient outcomes.
Market Restraints
Despite its effectiveness, the high cost of RF ablation procedures limits accessibility for many patients, especially those without adequate health insurance. This financial burden hampers the broader adoption of RF ablation devices, highlighting the need for solutions to address healthcare disparities.
Market Trends
A notable trend in the market is the development of RF ablation devices with real-time monitoring capabilities. These devices offer more controlled and efficient ablations, optimizing the formation of non-conductive tissue areas and reducing operation time.
To Get A Discount On The Latest Report, Visit @https://www.emergenresearch.com/request-discount/2631
Segment Insights
Applications: The RF ablation devices market is segmented into surgical oncology, pain management, cardiology, cosmetology, gynecology, and others. The cardiology and cardiac rhythm management segment held the largest market share in 2022 due to the increasing preference for minimally invasive procedures like catheter ablation. The surgical oncology segment is also expected to grow, driven by the precision and tailored treatment options it offers.
Product Types: The market is divided into RF generators, disposables, and reusable devices. The disposables segment is anticipated to dominate due to their cost-effectiveness, while the reusable segment is expected to grow steadily due to environmental concerns and the push for sustainable healthcare practices.
End-Use: Hospitals are expected to hold the largest market share, given their increasing use of RF ablation devices for effective and less invasive treatments. Research laboratories are projected to experience the fastest growth, serving as hubs for innovation and the development of more efficient and precise RFA devices.
RFA Devices Top Companies and Competitive Landscape
The global Radiofrequency Ablation (RFA) devices market is moderately fragmented, with many large and medium-sized players accounting for majority of market revenue. Major businesses are using a variety of tactics, making mergers and acquisitions, strategic agreements, and contracts, as well as creating, experimenting with, and introducing more efficient RFA devices solutions.
Johnson & Johnson
Smith & Nephew Plc.
Abbott Laboratories
Stryker Corporation
Medtronic Plc.
Boston Scientific Corporation
Baylis Medical Company Inc.
Avanos Medical Inc.
AngioDynamics Inc.
RF Medical Co. Ltd.
AtriCure Inc.
MedSphere International Inc.
Diros Technology Inc.
Hologic, Inc.
Stryker
Arthrex
Misonix, Inc.
Elekta
Mantisse
MedWaves, Inc.
Browse Detailed Research Report @https://www.emergenresearch.com/industry-report/radiofrequency-ablation-devices-market
Radiofrequency Ablation (RFA) Devices Latest Industry News
On 17 October, 2023 Johnson & Johnson (J&J) MedTech is undergoing a two-year restructuring program for its DePuy Synthes orthopedic business. The restructuring aims to exit less profitable markets and product lines, enhancing profitability after a 2.6% sales growth in Q3. This program is expected to conclude by the end of 2025, with a cost estimate of USD 700 million to USD 800 million. While the restructuring can lead to modest revenue disruption over the next two years, J&J believes it will accelerate future growth and profitability. The CEO expressed optimism, especially regarding knee-related improvements, with an emphasis on securing a prominent position in high-growth orthopedic
On 19 May, 2023 Abbott gained FDA approval for its TactiFlex Ablation Catheter, Sensor Enabled, touted as the world's first flexible-tip ablation catheter with contact force technology. This catheter, which integrates with Abbott's EnSite X EP System, is designed to enhance the precision of visualizing heart anatomy, reducing procedure times and improving safety. The flexible tip incorporates a laser-cut pattern that adapts upon contact with the heart, directing fluid to targeted tissue. This design improves the positioning accuracy of catheter, ensuring consistent and effective therapy. The approval comes amid increasing competition in the cardiac ablation space, with companies such as J&J's Biosense Webster and Medtronic.
Radiofrequency Ablation Devices Market Segment Analysis
For the purpose of this report, Emergen Research has segmented the global Radiofrequency Ablation (RFA) devices market on the basis of product, application, end-use, and region:
Product Outlook (Revenue, USD Billion; 2019-2032)
RF Generators
Disposables
Cannulas
Needles
Reusables
Probes
Electrodes
Application Outlook (Revenue, USD Billion; 2019-2032)
Surgical Oncology
Pain Management
Cardiology & Cardiac Rhythm Management
Cosmetology
Gynecology
Others
End-use Outlook (Revenue, USD Billion; 2019-2032)
Hospitals
Ambulatory Surgical Centers (ASCs)
Research Laboratories
Regional Outlook (Revenue, USD Billion; 2019–2032)
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of Middle East & Africa
Buy Now: @https://www.emergenresearch.com/select-license/2631
Browse More Report By Emergen Research:
Splicing Tapes Market
https://www.emergenresearch.com/industry-report/splicing-tapes-market
Water Desalination Equipment Market
https://www.emergenresearch.com/industry-report/water-desalination-equipment-market
Atopic Dermatitis Drugs Market
https://www.emergenresearch.com/industry-report/atopic-dermatitis-drugs-market
Insulin Market
https://www.emergenresearch.com/industry-report/insulin-market
Data Center Cooling Market
https://www.emergenresearch.com/industry-report/data-center-cooling-market
Aniline Market
https://www.emergenresearch.com/industry-report/aniline-market
Telescopic Slides Market
https://www.emergenresearch.com/industry-report/telescopic-slides-market
Biotechnology Market
https://www.emergenresearch.com/industry-report/biotechnology-market
Expanded Polystyrene Market
https://www.emergenresearch.com/industry-report/expanded-polystyrene-market
Peracetic Acid Market
https://www.emergenresearch.com/industry-report/peracetic-acid-market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
X
LinkedIn
Distribution channels: Healthcare & Pharmaceuticals Industry
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release